270 related items for PubMed ID: 16598777
1. Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.
Levy G, Schmidli H, Punch J, Tuttle-Newhall E, Mayer D, Neuhaus P, Samuel D, Nashan B, Klempnauer J, Langnas A, Calmus Y, Rogiers X, Abecassis M, Freeman R, Sloof M, Roberts J, Fischer L.
Liver Transpl; 2006 Nov; 12(11):1640-8. PubMed ID: 16598777
[Abstract] [Full Text] [Related]
2.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
3.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
4.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
5. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
Schweiger M, Wasler A, Prenner G, Stiegler P, Stadlbauer V, Schwarz M, Tscheliessnigg K.
Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176
[Abstract] [Full Text] [Related]
6. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E.
Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
[Abstract] [Full Text] [Related]
7. 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients.
Tedesco-Silva H, Vitko S, Pascual J, Eris J, Magee JC, Whelchel J, Civati G, Campbell S, Alves-Filho G, Bourbigot B, Garcia VD, Leone J, Esmeraldo R, Rigotti P, Cambi V, Haas T, 2306 and 2307 study groups.
Transpl Int; 2007 Jan; 20(1):27-36. PubMed ID: 17181650
[Abstract] [Full Text] [Related]
8. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience.
Li JT, Danguilan RA, Cabanayan-Casasola CB, Talusan-Tomacruz Y, Ona ET.
Transplant Proc; 2008 Sep; 40(7):2211-3. PubMed ID: 18790195
[Abstract] [Full Text] [Related]
9. Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships.
Kovarik JM, Snell GI, Valentine V, Aris R, Chan CK, Schmidli H, Pirron U.
J Heart Lung Transplant; 2006 Apr; 25(4):440-6. PubMed ID: 16563975
[Abstract] [Full Text] [Related]
10. Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin.
Lehmkuhl H, Hetzer R.
J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S201-5; discussion S210-1. PubMed ID: 15774323
[Abstract] [Full Text] [Related]
11. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
Albano L, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrançois N, Charpentier B, Blanc AS, Di Giambattista F, Dantal J, RAD A2420 Study Group.
Transplantation; 2009 Jul 15; 88(1):69-76. PubMed ID: 19584683
[Abstract] [Full Text] [Related]
12. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience.
Santos SM, Carlos CM, Cabanayan-Casasola CB, Danguilan RA.
Transplant Proc; 2012 Jan 15; 44(1):154-60. PubMed ID: 22310603
[Abstract] [Full Text] [Related]
13. A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine.
Montagnino G, Sandrini S, Iorio B, Schena FP, Carmellini M, Rigotti P, Cossu M, Altieri P, Salvadori M, Stefoni S, Corbetta G, Ponticelli C.
Nephrol Dial Transplant; 2008 Feb 15; 23(2):707-14. PubMed ID: 17890244
[Abstract] [Full Text] [Related]
14. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F.
Liver Transpl; 2009 Oct 15; 15(10):1262-9. PubMed ID: 19790150
[Abstract] [Full Text] [Related]
15. Everolimus versus azathioprine in a cyclosporine and ketoconazole-based immunosuppressive therapy in kidney transplant: 3-year follow-up of an open-label, prospective, cohort, comparative clinical trial.
Gonzalez F, Espinoza M, Herrera P, Rocca X, Reynolds E, Lorca E, Roessler E, Hidalgo J, Espinoza O.
Transplant Proc; 2010 Oct 15; 42(1):270-2. PubMed ID: 20172327
[Abstract] [Full Text] [Related]
16. Long-term results of kidney transplantation with cyclosporine- and everolimus-based immunosuppression.
Iaria G, Pisani F, Iorio B, Lucchesi C, De Luca L, Ielpo B, D'Andria D, Tariciotti L, Tisone G.
Transplant Proc; 2006 May 15; 38(4):1018-9. PubMed ID: 16757249
[Abstract] [Full Text] [Related]
17. Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis.
Viganò M, Tuzcu M, Benza R, Boissonnat P, Haverich A, Hill J, Laufer G, Love R, Parameshwar J, Pulpón LA, Renlund D, Abeywickrama K, Cretin N, Starling RC, Eisen HJ, RAD B253 Study Group.
J Heart Lung Transplant; 2007 Jun 15; 26(6):584-92. PubMed ID: 17543781
[Abstract] [Full Text] [Related]
18. Multicenter trial of everolimus in pediatric renal transplant recipients: results at three year.
Ettenger R, Hoyer PF, Grimm P, Webb N, Loirat C, Mahan JD, Mentser M, Niaudet P, Offner G, Vandamme-Lombaerts R, Hexham JM, Everolimus Pediatric Study Group.
Pediatr Transplant; 2008 Jun 15; 12(4):456-63. PubMed ID: 18466433
[Abstract] [Full Text] [Related]
19. Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study.
Bruyn GA, Tate G, Caeiro F, Maldonado-Cocco J, Westhovens R, Tannenbaum H, Bell M, Forre O, Bjorneboe O, Tak PP, Abeywickrama KH, Bernhardt P, van Riel PL, RADD Study Group.
Ann Rheum Dis; 2008 Aug 15; 67(8):1090-5. PubMed ID: 18037627
[Abstract] [Full Text] [Related]
20. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
Baboolal K.
Transplantation; 2003 Apr 27; 75(8):1404-8. PubMed ID: 12717239
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
